Did You Know...
...When G.G. Hubbard learned of his future son-in-law's invention, he called it "only a toy." His daughter was engaged to a young man named Alexander Graham Bell.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120039964 | NOVEL FORMULATIONS OF FAT-SOLUBLE ACTIVE INGREDIENTS WITH HIGH BIOAVAILABILITY The present invention relates to formulations of a pharmacological effective fat-soluble active ingredient with a high bioavailability of said fat-soluble active ingredient as well as to their manufacture and use as dietary supplement, food, feed, personal care product ... | 02/16/2012 |
| 20120035141 | CYCLOALKYL-HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT The present invention relates to novel cycloalkyl-hydroxyl compounds, compositions comprising hydroxyl compounds, and methods useful for treating and preventing a variety of diseases and conditions such as, but not limited to aging, Alzheimer's Disease, cancer, cardiova... | 02/09/2012 |
| 20110224723 | CYANOACRYLATE TISSUE ADHESIVES A tissue adhesive including cyanoacrylate and polyethylene glycol (PEG), wherein the PEG remains a polyether and wherein the tissue adhesive is bioabsorbable. A tissue adhesive including cyanoacrylate bulk monomer and cyanoacrylate nanoparticles containing a therapeutic... | 09/15/2011 |
| 20110197781 | STABILISATION OF AQUEOUS MINERAL PREPARATIONS BY REUTERIN The present invention relates to a process for stabilizing aqueous preparations of minerals by adding reuterin to the aqueous preparations, to the use of reuterin for the stabilization of such aqueous mineral preparations, and the aqueous mineral preparations containing... | 08/18/2011 |
| 20110123462 | BIOFILM DISRUPTIVE COMPOSITIONS In certain embodiments, the present invention relates to compounds, compositions, and methods for disrupting biofilms. In some embodiments, the compounds and compositions comprise unsaturated long chain alcohols and/or aldehydes, or combinations of such compounds. In fu... | 05/26/2011 |
| 20110117156 | COMPOSITIONS AND ARTICLES CONTAINING AN ACTIVE LIQUID IN A POLYMERIC MATRIX AND METHODS OF MAKING AND USING THE SAME Described herein are compositions and articles containing a polymeric matrix and an active liquid intermixed with at least a portion of the polymeric matrix. Methods of making and using the compositions and articles are also described herein.... | 05/19/2011 |
| 20110086761 | COMPOSITIONS AND METHODS TO CONTROL OOMYCETE FUNGAL PATHOGENS The present invention relates to fungicidal compositions and their use for controlling oomycete pathogen induced disease or diseases in one or more plants.... | 04/14/2011 |
| 20100226949 | INSECT REPELLENT AND ATTRACTANTS The disclosure provides compounds useful as insect repellents and compositions comprising such repellents. The disclosure further provides insect traps.... | 09/09/2010 |
| 20100226875 | CONTROLLED RELEASE OF ACTIVE COMPOUNDS FROM DYNAMIC MIXTURES The present invention relates to a dynamic mixture in the form of a dynamic mixture obtained by reacting together, in the presence of water, at least one O-substituted hydroxylamine or S-substituted thiohydroxylamine derivative with at least one perfuming, flavoring, in... | 09/09/2010 |
| 20100189817 | Treating Glaucoma Provided herein are methods of protecting all or a portion of the optic nerve fiber layer within the optic nerve/lamina cribrosa (ONLC) complex in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of an agent th... | 07/29/2010 |
| 20100040594 | FORMULATIONS FOR NONSURGICAL EXOGENOUS CROSSLINK THERAPY Improved methods and compositions for the treatment of native tissues with crosslinkers are provided. The methods and compositions will find particular use in increasing resistance to tearing, fissuring, rupturing, and/or delamination.... | 02/18/2010 |
| 20100016346 | ELASMOBRANCH-REPELLING DOMPOUNDS AND METHODS OF USE Compounds for repelling elasmobranch having an aldehyde or derivative, a carboxylic acid a derivative, a ketone or a derivative thereof, a di-ketone or a derivative thereof, a pyridine or derivative thereof, or an antipyrine or a derivative thereof and methods of use th... | 01/21/2010 |
| 20090298950 | CYCLOPENTANE/CYCLOPENTENE ALDEHYDE OR KETONE DERIVATIVES AND THEIR USE AS ODORANTS The present invention relates to campholytic aldehyde condensates of formula (I) wherein R1-R5 have the same meaning as given in the specification. It furth... | 12/03/2009 |
| 20090156686 | Composition containing higher fatty acid derivative and foods and drinks An object of the invention is to provide a composition containing a higher fatty acid derivative, which can be easily produced at low cost, is effective as an agent for prevention and treatment of osteoporosis induced by various factors such as diet, dietary restriction... | 06/18/2009 |
| 20090111894 | Method of Preventing Microbial Growth There is provided a method of preventing microbial growth in an article, such as a consumer product or packaging material, whereby said article is treated with an effective amount of hydroxyacetaldehyde.... | 04/30/2009 |
| 20090069417 | CAROTENOID OXIDATION PRODUCTS AS CHEMOPREVENTIVE AND CHEMOTHERAPEUTIC AGENTS The present invention relates to a method for the chemoprevention and treatment of cancer, by administering a pharmaceutical composition comprising a carotenoid derivative, such as a derivative of lycopene, a- and b-carotene, phytoene, phytofluene, lutein, zeaxanthin, Î... | 03/12/2009 |
| 20090042982 | METHOD FOR TREATING NEUROLOGICAL DISORDERS USING ACETONE DERIVATIVES The present invention provides a method of treating neurological disorders, such as epilepsy, comprising administering an effect amount of an acetone derivative having the formula R1—C(X)—R2, to an animal in need thereof. Such acetone derivativ... | 02/12/2009 |
| 20080319088 | Aldehyde Compositions and Methods for Providing Fragrance Containing the Same The present invention is directed to the novel aldehyde compounds, represented by the general structure of Formula I set forth below: wherein R is a straight, branched hydrocarbon moiety consisting of 3 to 10... | 12/25/2008 |
| 20080274077 | Method for Treating Neurological Disorders The present invention is based on the discovery that suppressing the activity of the Nogo receptor (NgR) alone does not result in extensive axon regeneration unless the intrinsic growth program of neurons is also activated Accordingly, the present invention is directed ... | 11/06/2008 |
| 20080118591 | Bactericidal Formulations The invention relates to bactericidal formulations that come into contact with human body, particularly wash formulations including liquid soaps, comprising perfume ingredients active against gram-negative bacteria. Such compositions contact the target site, for example... | 05/22/2008 |
| 20080039531 | Compositions, and kits comprising targeted aldehyde or acetal protease inhibitor compounds for treating muscle disorders Described herein are compounds that comprise a carrier residue that is or is an analog of carnitine, an optional linker group, and a residue of a protease inhibitor comprising an aldehyde group or acetal derivatives of the aldehyde group, and pharmaceutical compositions... | 02/14/2008 |
| 20080031961 | Benefit agent containing delivery particle The present invention relates to benefit agent containing delivery particles, compositions comprising said particles, and processes for making and using the aforementioned particles and compositions. When employed in compositions, for example, personal care, cleaning or... | 02/07/2008 |
| 20080026984 | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof A method is disclosed for treating inflammatory disease in an animal in need thereof by administering to the animal a pharmaceutical composition containing an anti-inflammatory effective amount of an organic aldehyde compound or a derivative thereof in a pharmaceuticall... | 01/31/2008 |
| 20080021098 | Antifungal Compositions A method of simultaneously preventing the growth of fungi on substrates, particularly those exposed to an atmosphere, and imparting thereto a desired odour, by applying thereto a fragrance whose fragrant properties are derived mainly from the presence in the fragrance o... | 01/24/2008 |
| 20080015249 | CANCER TREATMENT COMPOSITIONS AND METHOD USING NATURAL PLANT ESSENTIAL OILS Pharmaceutical compositions containing plant essential oils, natural or synthetic, or mixtures or derivatives thereof, for the prevention and treatment of soft tissue cancer in mammals. ... | 01/17/2008 |
| 20070281891 | Lock solution for medical devices The invention relates to a lock solution for medical devices comprising carbohydrates and/or glucose degradation products as antimicrobial agent(s). ... | 12/06/2007 |
| 20070219120 | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof A method is disclosed for treating inflammatory disease in an animal in need thereof by administering to the animal a pharmaceutical composition containing an anti-inflammatory effective amount of an organic aldehyde compound or a derivative thereof in a pharmaceuticall... | 09/20/2007 |
| 20070207220 | Method for improving sleep behaviors The invention relates to a method for improving the sleep behaviors of a human comprising the administration of a sensory regimen which comprises: a. the administration of a first sensory experience comprising topically applying to the skin or hair of the human a cleans... | 09/06/2007 |
| 20070207981 | MICRO-ENCAPSULATION OF VOLATILE COMPOUNDS INTO CYCLODEXTRINS: A NEW TECHNOLOGY TO REDUCE POST HARVEST LOSSES Systems are provided for preventing post harvest fungal diseases of food systems, such as but not limited to fresh produce, such as but not limited to berries (e.g., blueberries). For example, various anti-fungal compounds can incorporated or encapsulated into cyclodext... | 09/06/2007 |
| 20070202141 | Synthetic Aggregation Pheromone For Manipulating The Behaviour Of Codling Moth, Cydia Pomonella, Larvae This invention relates to a composition and procedure for manipulating the behaviour of codling moth larvae, Cydia pomonella (L.) (Lepidoptera: Olethreutidae). In particular, this invention relates to the use of specific pheromone components for manipulating the ... | 08/30/2007 |
| 20070135376 | METHOD TO REDUCE OXIDATIVE DAMAGE AND IMPROVE MITOCHONDRIAL EFFICIENCY Methods for the reduction of mitochondrial oxidative damage and improved mitochondrial efficiency in an animal by administration of medium chain triglycerides or prodrug of medium chain triglycerides to the animal are provided. ... | 06/14/2007 |
| 20070135526 | Synthesis of (1)-beta-elemene, (-)-beta-elemenal, (-)-beta-elemenol, (-)-beta-elemene fluoride and their analogues, intermediates, and composition and uses thereof The present invention provides convergent processes for preparing (−)-beta-elemene, (−)-beta-elemenal, (−)-beta-elemenol, and (−)-beta-elemene fluoride and analogues thereof. Also provided are intermediates useful for preparing (−)-beta-elemene. The present in... | 06/14/2007 |
| 20070026457 | Screening method The present invention provides a method of screening an agent for the prevention/treatment of cancer. More specifically, the present invention provides a screening method/screening kit for screening a compound or its salt that changes the binding properties of a protein... | 02/01/2007 |
| 20070010586 | Enhanced tuburculocidal activity and decreased fumes from glutaraldehyde disinfectant using acetate salts and alcohol The addition of alcohol plus acetate salts unexpectedly enhanced the tuberculocidal activity of glutaraldehyde, and decreased the fumes of glutaraldehyde from the formula of a high-level disinfectant. ... | 01/11/2007 |
| 20060240131 | PROCESS FOR EFFECTING THE RELAXATION OF MUSCLES OF A HUMAN BY MEANS OF FRAGRANCE Described is a process for effecting the relaxation of a tensive back, shoulder or neck muscle of a human mammal for a substantial period of time. The process of our invention consists essentially of the step of continuously or periodically administering to said human m... | 10/26/2006 |
| 20060210593 | Methods of making and methods of using antiseptic disinfectant, cosmetic and toiletries, medicine or food containing the same The present invention relates to methods for producing and using antiseptic disinfectant, cosmetic and toiletries, medicine or food and method for antiseptically disinfecting a cosmetic and toiletries, medicine or food. The cosmetic and toiletries, medicine or food cont... | 09/21/2006 |
| 20060104997 | Monoterpene compositions and uses thereof The present invention relates to pharmaceutical compositions and methods for the mucosal and oral administration of monoterpenes and derivatives thereof. The compositions of this invention further comprise one or more surfactants and cosolvents and are in the form of se... | 05/18/2006 |
| 20050238729 | Inhibition of biogenic sulfide production via biocide and metabolic inhibitor combination Biogenic sulfide production is synergistically inhibited by treating sulfate-reducing bacteria (SRB) with a biocide and a metabolic inhibitor. The biocide directly kills a first portion of the SRB. The metabolic inhibitor inhibits sulfate-reducing growth of a second por... | 10/27/2005 |
| 20050209344 | Behavior-disrupting agent and behavior-disrupting method of Argentine ant Provided are a behavior-disrupting agent of Argentine ants for controlling them or suppressing their reproduction is a safer and more effective manner, and the behavior-disrupting method of them. More specifically, a behavior-disrupting agent of Argentine ants comprisin... | 09/22/2005 |
| 20050129725 | Method of controlling pest and pest control agent A method for controlling pests, which includes allowing a gaseous compound having the formula (I) wherein is a single bond or a double bond, to be present at a concentration of 0.001-20,000 μg/L in a space where pest repellence is intended, and a pest cont... | 06/16/2005 |
